Sonoma Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2012 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2023.
  • Sonoma Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 1.46M shares, a 168% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 9.09M shares, a 168% increase from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.39M shares.
  • Sonoma Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 2.65K shares.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 9.09M +5.7M +168% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-17
2022 3.39M +3.39M Apr 1, 2022 Mar 31, 2023 10-K 2024-06-17
2021 2.65K* Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
2014 9.66M +2.76M +40% Apr 1, 2014 Mar 31, 2015 10-K 2015-06-16
2013 6.9M +1.92M +38.6% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-16
2012 4.98M Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.